Post by
DanielDarden123 on May 06, 2021 1:09pm
Valuation
As a long term holder, valuation has always been a factor for consideration. However, many factors enter into that .evaluation. With a stellar balance sheet, $50M of working capital, and a low POR a EV/Ebitda multiple of 10 seems reasonable. Cosmetics accounted for half of the decrease in revenue from their legacy business so an improvement post pandemic would provide growth Q/Q going forward. Presumably demand would increase with increasing socializing. In the event of a prolonged pandemic, the last year results demonstrate stability.
Comment by
HermannHaller on Feb 25, 2022 12:02pm
Might be time to revisit this one? I think I will wait to see the Q4 results.